Senior Director, BD Transactions (1 of 2)

The Senior Director, Business Development Transactions supports the execution of complex partnering, licensing, collaboration and acquisition deals that shape CSL's future portfolio and scientific leadership. This role translates TA insights, enterprise strategy and cross-functional perspectives into high-quality transaction structures and negotiation outcomes. It serves as a senior deal strategist, ensuring CSL secures partnerships that deliver scientific, commercial, and financial value while managing enterprise risk with discipline.

RESPONSIBILITIES AND ACCOUNTABILITIES

List the essential job duties and responsibilities in order of priority or time spent on each. Include only those items that are the sole or primary reason the job exists, items that require specialized skills or training, and items that demand a significant portion of time to perform (Do not list competencies, education, training requirements, etc.).

Transaction Execution Leadership

• Lead execution of CSL's high-priority licensing agreements, research collaborations, asset acquisitions, equity-linked deals and divestitures
  

• Translate TA evaluation assumptions, due diligence findings and strategic intent into precise negotiation strategies, deal terms and execution plans
  

Deal Structuring & Negotiation Strategy

• Shape deal structures, financial constructs and key contractual terms that balance scientific opportunity with commercial viability and risk tolerance
  

• Partner closely with BD TA, Legal/IP and Finance to define defensible positions, valuation baselines, negotiation boundaries and fallback strategies
  

• Working closely with BD TA, represent CSL as a senior negotiator in external partner discussions, ensuring alignment with enterprise priorities and long-term alliance success
  

Diligence Leadership

• Lead cross-functional diligence programs covering scientific, clinical, regulatory, commercial, CMC, supply, legal and operational domains
  

• Ensure diligence findings directly inform deal shaping, risk mitigation and integration planning.
  

• Drive clarity and transparency of risks, assumptions and trade-offs for governance stakeholders.
  

Governance & Decision Support

• Prepare high-quality PRISM and senior leadership decision materials that clearly articulate deal rationale, valuation considerations, risks and strategic impact.
  

• Ensure all transactions adhere to CSL governance standards, compliance requirements and industry best practices.
  

• Facilitate timely decision-making by surfacing issues early and driving alignment across functions.
  

Enterprise Orchestration & Cross-Functional Partnership

• Align stakeholders across R&D, Commercial, Technical Operations, Corporate Strategy, Finance and Enterprise Alliance Management.

• Drive enterprise judgement by ensuring rigorous debate, transparent trade-offs and alignment to long-range strategy.
  

• Collaborate with BD TA to ensure transaction structures reflect scientific and commercial assumptions.
  

Post-Signature Handover & Early-Life Support

• Ensure smooth transition of executed deals to Alliance Management and operational owners, including risk registers, obligations and communications.
  

• Provide early-life issue resolution support during the initial stabilisation period of partnerships and alliances.
  

Team Leadership & Capability Building

• Mentor and guide more junior members of the team, strengthening CSL's internal dealmaking capability.
  

• Contribute to developing tools, templates, negotiation frameworks and knowledge repositories that elevate the function.
  

• Drive a culture of discipline, strategic thinking, and deal quality across the BD Transactions team.
  

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.

Client-provided location(s): King of Prussia, PA

Job ID: CSL_FGB-R-270613

Employment Type: FULL_TIME

Posted: 2026-01-23T23:31:29